Unit of Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Ann Surg Oncol. 2013 May;20(5):1639-45. doi: 10.1245/s10434-012-2690-y. Epub 2012 Dec 28.
Little is known about the long-term effects of surgical approach and type of anastomosis in the surgical treatment of esophageal cancer on patient-reported outcomes.
A Swedish nationwide, population-based cohort study included patients undergoing esophagectomy for esophageal cancer in 2001-2005. The predefined exposures included surgical approach (transhiatal or transthoracic) and anastomotic technique (hand-sewn or mechanical). The outcomes were esophageal-specific symptoms 3 years after the surgery. Symptoms were measured using the cancer-specific quality of life questionnaire, the QLQ-C30, supplemented by an esophageal cancer-specific module (QLQ-OES18), both developed by the European Organisation for Research and Treatment of Cancer. Logistic regression models were used to estimate relative risk, expressed as odds ratios (OR) with 95 % confidence intervals (CI), of experiencing symptoms as assessed by the questionnaires.
Among the 178 included patients, there was an 84 % participation rate. No statistically significant differences were found regarding surgical approach. However, point estimates indicate that patients operated on with a transhiatal approach had a lower risk for symptoms of nausea and vomiting (OR = 0.5, 95 % CI 0.1-1.9), diarrhea (OR = 0.5, 95 % CI 0.2-1.8), and trouble swallowing (OR = 0.4, 95 % CI 0-3), and a slightly higher risk for loss of appetite (OR = 2, 95 % CI 0.7-5.6) compared with patients operated on with a transthoracic approach. Anastomotic technique did not seem to influence the risk for any of the selected symptoms.
Surgical approach and type of anastomosis do not seem to influence the risk of general and esophageal-specific cancer symptoms 3 years after surgery for esophageal cancer.
对于食管癌手术中手术入路和吻合方式对患者报告结局的长期影响知之甚少。
这是一项瑞典全国范围内基于人群的队列研究,纳入了 2001 年至 2005 年间接受食管癌切除术的患者。预设的暴露因素包括手术入路(经胸或经食管裂孔)和吻合技术(手工或机械)。术后 3 年的食管特异性症状为研究结局。症状使用欧洲癌症研究与治疗组织开发的癌症特异性生活质量问卷,包括 QLQ-C30 量表及其食管癌症特异性模块(QLQ-OES18)进行评估。使用逻辑回归模型估计相对风险,以问卷评估的比值比(OR)表示,95%置信区间(CI)。
在纳入的 178 例患者中,有 84%的患者参与了研究。手术入路方面未发现统计学差异。然而,点估计表明,经食管裂孔入路手术的患者发生恶心和呕吐(OR=0.5,95%CI 0.1-1.9)、腹泻(OR=0.5,95%CI 0.2-1.8)和吞咽困难(OR=0.4,95%CI 0-3)的风险较低,而食欲减退的风险略高(OR=2,95%CI 0.7-5.6)。与经胸入路手术的患者相比,吻合技术似乎并不影响任何选定症状的风险。
食管癌手术后 3 年,手术入路和吻合方式似乎不会影响一般和食管特异性癌症症状的风险。